B
55.21
1.38 (2.56%)
| Previous Close | 53.83 |
| Open | 55.86 |
| Volume | 1,983,811 |
| Avg. Volume (3M) | 2,448,263 |
| Market Cap | 8,637,786,112 |
| Price / Earnings (TTM) | 104.17 |
| Price / Earnings (Forward) | 24.57 |
| Price / Sales | 7.15 |
| Price / Book | 4.28 |
| 52 Weeks Range | |
| Earnings Date | 6 May 2026 |
| TTM Dividend Yield | 0.58% |
| Profit Margin | 10.89% |
| Operating Margin (TTM) | 14.10% |
| Diluted EPS (TTM) | 0.830 |
| Quarterly Revenue Growth (YOY) | 4.20% |
| Quarterly Earnings Growth (YOY) | -54.00% |
| Total Debt/Equity (MRQ) | 20.99% |
| Current Ratio (MRQ) | 3.71 |
| Operating Cash Flow (TTM) | 264.85 M |
| Levered Free Cash Flow (TTM) | 244.41 M |
| Return on Assets (TTM) | 5.23% |
| Return on Equity (TTM) | 6.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Bio-Techne Corp | Bullish | Mixed |
AIStockmoo Score
0.9
| Analyst Consensus | 5.0 |
| Insider Activity | -3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.90 |
|
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 1.07% |
| % Held by Institutions | 106.11% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Mairs & Power Inc | 31 Dec 2025 | 2,767,539 |
| Df Dent & Co Inc | 31 Dec 2025 | 2,592,215 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 80.00 (TD Cowen, 44.90%) | Buy |
| 80.00 (Citigroup, 44.90%) | Buy | |
| Median | 77.50 (40.37%) | |
| Low | 65.00 (Stifel, 17.73%) | Hold |
| Average | 74.67 (35.25%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 66.01 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 06 Feb 2026 | 76.00 (37.66%) | Buy | 66.78 |
| Citigroup | 05 Feb 2026 | 80.00 (44.90%) | Buy | 65.86 |
| Evercore ISI Group | 05 Feb 2026 | 68.00 (23.17%) | Hold | 65.86 |
| Stifel | 05 Feb 2026 | 65.00 (17.73%) | Hold | 65.86 |
| TD Cowen | 05 Feb 2026 | 80.00 (44.90%) | Buy | 65.86 |
| UBS | 05 Feb 2026 | 79.00 (43.09%) | Buy | 65.86 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BOHNEN SHANE | - | 53.13 | -740 | -39,316 |
| Aggregate Net Quantity | -740 | |||
| Aggregate Net Value ($) | -39,316 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 53.13 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BOHNEN SHANE | Officer | 03 Apr 2026 | Disposed (-) | 740 | 53.13 | 39,316 |
| BOHNEN SHANE | Officer | 03 Apr 2026 | Option execute | 2,259 | - | - |
| Date | Type | Details |
|---|---|---|
| 04 Feb 2026 | Announcement | Bio-Techne Declares Dividend |
| 04 Feb 2026 | Announcement | Bio-Techne Releases Second Quarter Fiscal 2026 Results |
| 02 Feb 2026 | Announcement | Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative |
| 28 Jan 2026 | Announcement | Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers |
| 20 Jan 2026 | Announcement | Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results |
| TTM Dividend Yield | 0.58% |
| 5Y Average Dividend Yield | 0.79% |
| Payout Ratio | 38.55% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 13 Feb 2026 | - | 27 Feb 2026 | 0.08 Cash |
| 17 Nov 2025 | - | 28 Nov 2025 | 0.08 Cash |
| 18 Aug 2025 | - | 29 Aug 2025 | 0.08 Cash |
| 19 May 2025 | - | 30 May 2025 | 0.08 Cash |
| 14 Feb 2025 | 05 Feb 2025 | 28 Feb 2025 | 0.08 Cash |
| 08 Nov 2024 | 30 Oct 2024 | 22 Nov 2024 | 0.08 Cash |
| 19 Aug 2024 | - | 30 Aug 2024 | 0.08 Cash |
| 10 May 2024 | - | 24 May 2024 | 0.08 Cash |
| 09 Feb 2024 | - | 26 Feb 2024 | 0.08 Cash |
| 09 Nov 2023 | - | 24 Nov 2023 | 0.08 Cash |
| 17 Aug 2023 | - | 01 Sep 2023 | 0.08 Cash |
| 12 May 2023 | - | 26 May 2023 | 0.08 Cash |
| 10 Feb 2023 | - | 27 Feb 2023 | 0.08 Cash |
| 10 Nov 2022 | - | 28 Nov 2022 | 0.32 Cash |
| 12 Aug 2022 | - | 29 Aug 2022 | 0.32 Cash |
| 13 May 2022 | - | 27 May 2022 | 0.32 Cash |
| 10 Feb 2022 | - | 25 Feb 2022 | 0.32 Cash |
| 10 Nov 2021 | - | 26 Nov 2021 | 0.32 Cash |
| 13 Aug 2021 | - | 27 Aug 2021 | 0.32 Cash |
| 14 May 2021 | - | 28 May 2021 | 0.32 Cash |
| 11 Feb 2021 | - | 26 Feb 2021 | 0.32 Cash |
| 13 Nov 2020 | - | 27 Nov 2020 | 0.32 Cash |
| 17 Aug 2020 | - | 28 Aug 2020 | 0.32 Cash |
| 08 May 2020 | - | 22 May 2020 | 0.32 Cash |
| 13 Feb 2020 | - | 28 Feb 2020 | 0.32 Cash |
| 07 Nov 2019 | - | 22 Nov 2019 | 0.32 Cash |
| 15 Aug 2019 | - | 30 Aug 2019 | 0.32 Cash |
| 09 May 2019 | - | 24 May 2019 | 0.32 Cash |
| 14 Feb 2019 | - | 01 Mar 2019 | 0.32 Cash |
| 08 Nov 2018 | - | 23 Nov 2018 | 0.32 Cash |
| 16 Aug 2018 | - | 31 Aug 2018 | 0.32 Cash |
| 11 May 2018 | - | 25 May 2018 | 0.32 Cash |
| 15 Feb 2018 | - | 02 Mar 2018 | 0.32 Cash |
| 09 Nov 2017 | - | 24 Nov 2017 | 0.32 Cash |
| 16 Aug 2017 | - | 01 Sep 2017 | 0.32 Cash |
| 17 May 2017 | - | 02 Jun 2017 | 0.32 Cash |
| 15 Feb 2017 | - | 03 Mar 2017 | 0.32 Cash |
| 09 Nov 2016 | 31 Oct 2016 | 28 Nov 2016 | 0.32 Cash |
| 25 Aug 2016 | 17 Aug 2016 | 12 Sep 2016 | 0.32 Cash |
| 11 May 2016 | 26 Apr 2016 | 27 May 2016 | 0.32 Cash |
| 10 Feb 2016 | - | 26 Feb 2016 | 0.32 Cash |
| 10 Nov 2015 | - | 27 Nov 2015 | 0.32 Cash |
| 13 Aug 2015 | 06 Aug 2015 | 28 Aug 2015 | 0.32 Cash |
| 13 May 2015 | 05 May 2015 | 29 May 2015 | 0.32 Cash |
| 11 Feb 2015 | 03 Feb 2015 | 27 Feb 2015 | 0.32 Cash |
| 06 Nov 2014 | 30 Oct 2014 | 24 Nov 2014 | 0.32 Cash |
| 19 Aug 2014 | 11 Aug 2014 | 29 Aug 2014 | 0.31 Cash |
| 07 May 2014 | 28 Apr 2014 | 23 May 2014 | 0.31 Cash |
| 12 Feb 2014 | 04 Feb 2013 | 28 Feb 2014 | 0.31 Cash |
| 07 Nov 2013 | 31 Oct 2013 | 25 Nov 2013 | 0.31 Cash |
| 14 Aug 2013 | 06 Aug 2013 | 30 Aug 2013 | 0.3 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.080 | 1 | 0.15 |
| 2025 | 0.320 | 4 | 0.54 |
| 2024 | 0.320 | 4 | 0.44 |
| 2023 | 0.320 | 4 | 0.42 |
| 2022 | 1.28 | 4 | 1.54 |
| 2021 | 1.28 | 4 | 0.99 |
| 2020 | 1.28 | 4 | 1.61 |
| 2019 | 1.28 | 4 | 2.33 |
| 2018 | 1.28 | 4 | 3.54 |
| 2017 | 1.28 | 4 | 3.95 |
| 2016 | 1.28 | 4 | 4.98 |
| 2015 | 1.28 | 4 | 5.69 |
| 2014 | 1.25 | 4 | 5.41 |
| 2013 | 0.610 | 2 | 2.58 |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |